Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow-up,Brain and Behavior

当前位置： X-MOL 学术 › Brain Behav. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow-up
Brain and Behavior ( IF 2.6 ) Pub Date : 2021-07-21 , DOI: 10.1002/brb3.2257
Tom J M van Mierlo _{1,

2} , Elisabeth M J Foncke ₁ , Bart Post ₃ , Ben A Schmand ₄ , Bastiaan R Bloem ₃ , Barbera van Harten ₅ , Gerrit Tissingh ₆ , Alexander G Munts ₂ , Rob J de Haan ₇ , Rob M A de Bie ₈ ,

Affiliation

Visual hallucinations are common in patients with Parkinson's disease and represent probably the major independent predictor for cognitive deterioration and nursing home placement.

中文翻译：